Cambridge Innovation Capital (CIC) is a leading venture capital firm embedded within the Cambridge ecosystem, focusing on deep-tech and life sciences companies. Established in 2013, CIC manages over £600 million in assets and has invested in more than 40 companies across sectors such as artificial intelligence, quantum technologies, therapeutics, and digital health. The firm leverages its unique relationship with the University of Cambridge to access cutting-edge research and talent, aiming to support the commercialization of innovative ideas and foster the growth of globally impactful businesses.

CIC's portfolio includes notable companies like Pragmatic Semiconductor, Riverlane, and Microbiotica, reflecting its commitment to advancing transformative technologies.